Dubai: The Emirates Drug Establishment (EDE) has reiterated its ban on advertising or promoting medical products through social media influencers, stressing that all medical product advertisements must receive its approval before publication or circulation.
The announcement came during the Medical Product Advertising Customer Council, organised by the establishment at the Government Accelerators Centre in Emirates Towers, Dubai, with the participation of industry representatives, partners and customers.
Get updated faster and for FREE: Download the Gulf News app now - simply click here.
The council, held on November 18, examined the latest regulatory requirements governing medical advertising, including restrictions on promotional claims and the use of digital platforms.
The establishment emphasised that advertisements must comply with approved regulatory standards, regardless of the medium used, including printed materials, television, radio, outdoor advertising screens, websites and social media platforms.
Participants also reviewed the rules governing advertisements for prescription-only medicines, including the restrictions and approval requirements applicable to such promotional content.
The discussions addressed the procedures for obtaining advertising approval through the establishment's electronic licensing system, including the documents and promotional materials applicants must submit depending on the type of advertisement and the platform on which it will appear.
The EDE stressed that medical advertisements must contain accurate, clear and verifiable information, consistent with the product's approved specifications and authorised uses.

